An artificially engineered "tumor bio-magnet" for collecting blood-circulating nanoparticles and magnetic hyperthermia. (27th March 2019)

• Record Type: Journal Article
• Authors: Liang, Bing; Yu, Kexiao; Ling, Yi; Kolios, Micheal; Exner, Agata; Wang, Zhigang; Hu, Bing; Zuo, Guoqing; Chen, Yu; Zheng, Yuanyi
• Is Part Of: Biomaterials science. Volume 7:Number 5(2019)
• Page Start: 1815
• Page End: 1824
• Publication Date: 2019-03-27
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1039/c8bm01658e
• Languages: English
• ISSNs: 2047-4830

Abstract

Abstract : We report a novel approach to transform a tumor into a "bio-magnet", to be magnetized on demand, in order to create an intrinsic tumor magnetic field, able to collect magnetic nanoparticles circulating in the blood and achieve simultaneous magnetic hyperthermia. Abstract : It is a great challenge to directly endow a tumor with specific functions for theranostic treatment. In this study, we report on a novel approach to transform a tumor into a "bio-magnet", to be magnetized on demand, in order to create an intrinsic tumor magnetic field that would collect magnetic nanoparticles (MNPs) circulating in the blood and achieve simultaneous magnetic hyperthermia. This was achieved by the localized intratumoral injection of liquid Nd2 Fe14 B/Fe3 O4 -PLGA, followed by solvent exchange that induces a liquid-to-solid transformation. After the magnetism charging process, the solid Nd2 Fe14 B/Fe3 O4 -PLGA implant was endowed with permanent magnetic properties and in situ created the magnetic field within the tumor tissue, making the tumor a "bio-magnet". After the creation of the bio-magnet, intravenously injected MNPs accumulated into the tumor tissue due to the tumor magnetic field. Importantly, both the in vitro and ex vivo results demonstrated the high efficiency of the implanted bio-magnet for magnetic hyperthermia. This new approach achieves magnetic targeting by creating a tumor "bio-magnet", which generates a strong magnetic field within the tumor, paving a new way for the development of an efficient targeting strategy for tumor therapy.